Literature DB >> 1545087

Use of standardized and conventional allergen extracts in prick skin testing.

B J Lavins1, W K Dolen, H S Nelson, R W Weber.   

Abstract

This study examined whether commercially available conventional and standardized allergen extracts differ enough in potency to affect routine prick skin test results. Extracts of white oak, timothy, Bermuda, Russian thistle, short ragweed, sagebrush, Alternaria, and cat dander were examined in allergic patients and in nonatopic subjects with no personal or family history of asthma, rhinitis, or eczema. Conventional nonstandardized extracts (1:10 or 1:20 wt/vol) from two sources were compared with three concentrations (100,000, 10,000, and 1000 AU/ml) of a single standardized extract. Preparations were compared in the allergic patients with computerized planimetry, and in all patients and subjects with a conventional skin test grading system. Skin test area for the conventional extracts generally fell between the 10,000 and 100,000 AU/ml concentrations of the standardized extract. Skin test reactivity to at least one allergen extract occurred in 31% of the nonatopic subjects; there was no difference between the number of 3+ and 4+ reactions for conventional and standardized extracts. Results indicate that standardized and conventional extracts are frequently similar, but are not directly interchangeable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545087     DOI: 10.1016/0091-6749(92)90371-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  2 in total

Review 1.  Skin testing and immunoassays for allergen-specific IgE.

Authors:  W K Dolen
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 10.817

2.  Evaluation of major mite allergens from European standardized commercial extracts for in vivo diagnosis: addressing the need for precision medicine.

Authors:  Ruperto González-Pérez; Paloma Poza-Guedes; Yvelise Barrios Del Pino; Víctor Matheu; Inmaculada Sánchez-Machín
Journal:  Clin Transl Allergy       Date:  2019-02-25       Impact factor: 5.871

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.